Drug Trial Radar · NCT00682500
Calfactant for Direct Acute Respiratory Distress Syndrome
Last checked: Nov 20, 2026Latest source record: Jul 24, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
332
Actual
Start
May 2008
Primary completion
Dec 2010
Study completion Feb 2011
Sponsor
- Lead sponsor
- Pneuma Pharmaceuticals IncorporatedAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 22, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will determine if administration of an suspension of calfactant, a lung surfactant, intratracheally in patients with Direct Acute Respiratory Distress Syndrome within 48 hours of requiring mechanical ventilation can decrease the mortality in patients with lethal disease and shorten the course of respiratory failure in patients with sub-lethal disease.
Conditions
- Respiratory Distress Syndrome, Adult
Interventions
CalfactantDrug
Intratracheal Instillation of 0.5 mL/cm of height of 60 mg/mL suspension in two aliquots at study entry. Repeat dosing 12 hours later if criteria are met.
Room Air (placebo)Drug
Administration of 0.5 ml/cm height of air at study entry into the trachea. Repeat dosing at 12 hours if criteria are met
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mortality RateTime frame: 90 days
Locations
32 sites in 6 countries. Site status is shown where the registry gives one.
University of Florida
Gainesville, Florida
Florida Hospital and Florida Children's Hospital
Orlando, Florida
Northwestern University-Chicago
Chicago, Illinois
West Suburban Hospital Medical Center
Oak Park, Illinois
Peoria Pulmonary Associates/OSF St. Francis Hospital
Peoria, Illinois
Clarian Health, Inc/Methodist Hospital
Indianapolis, Indiana
University of Iowa
Iowa City, Iowa
Creighton University
Omaha, Nebraska
Omaha Children's Hospital
Omaha, Nebraska
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Columbia Medical Center--Pediatrics
New York, New York
The Oregon Clinic
Portland, Oregon
Penn State University
Hershey, Pennsylvania
Baylor College of Medicine/Texas Children's Hospital
Houston, Texas
Uthscsa/Stvah
San Antonio, Texas
University of Virginia Health Science Center
Charlottesville, Virginia
INOVA Fairfax Hospital
Fairfax, Virginia
Medical College of Wisconsin
Milwaukee, Wisconsin
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Royal Columbian Hospital
New Westminster, British Columbia, Canada
British Columbia Children's Hospital
Vancouver, British Columbia, Canada
Surrey Memorial Hospital
Vancouver, British Columbia, Canada
Vancouver General Hospital
Vancouver, British Columbia, Canada
Kingston General Hospital
Kingston, Ontario, Canada
London Health Sciences Centre
London, Ontario, Canada
Ottawa Hospital
Ottawa, Ontario, Canada
Haemek Medical Center
Jerusalem, Israel
Rabin Medical Center
Jerusalem, Israel
Auckland City Hospital
Auckland, Auckland, New Zealand
Starship Children's Hospital
Auckland, New Zealand, New Zealand
Asan Medical Center
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.